.png)
A strategic site
Campus Grand Parc is a strategic 100,000 m² site (of which 45,000 m² will be available by the end of 2025), dedicated to biotechnology companies and industrial R&D teams building Europe's leading oncology cluster. Beyond this, Campus Grand Parc is a true living district, with diversified housing, shops, schools, parks and healthcare facilities, while retaining its distinctive scientific DNA.
Located just a few dozen metres from the Institut Gustave Roussy, close to Europe's most renowned research and healthcare centres (Institut Curie, AP-HP, UPS, IPP, Inserm...) and less than 20 minutes from the centre of Paris, the site will offer privileged access to infrastructures, technological platforms, clinical trials and the best experts in the field of oncology.
Spearheading this new district, the PSCC will move into Lab 116, by Perelis, the Campus' first operational building, in January 2025.
.jpg)
Spaces developed to meet the needs of innovators, start-ups, biotechs and manufacturers, stimulating exchanges and partnerships while offering easy access to cutting-edge technological and clinical platforms.
100 000 m²
« Campus Grand Parc is much more than a place to work, it's a true ecosystem of excellence designed to accelerate advances in the fight against cancer. Our ambition is to create a stimulating environment to boost exchanges between all the players in the oncology field, and help shape the future of treatments and diagnostics for the benefit of patients. »
Eric Vivier, PSCC president